Further investigation is needed on the use of NAM treatment to reduce the RAGE levels and to study the possible mechanism of neuroprotection in animal models of several diseases like AD and PD, as well ischemia, stroke, and traumatic brain injury. The gene discussed is AGER; the disease is stroke disorder.